Y Carcassonne

1.4k total citations
115 papers, 1.1k citations indexed

About

Y Carcassonne is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Y Carcassonne has authored 115 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 34 papers in Oncology and 24 papers in Genetics. Recurrent topics in Y Carcassonne's work include Acute Lymphoblastic Leukemia research (21 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Y Carcassonne is often cited by papers focused on Acute Lymphoblastic Leukemia research (21 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Y Carcassonne collaborates with scholars based in France, United States and Netherlands. Y Carcassonne's co-authors include D Maraninchi, P Mannoni, R. Favre, G Sébahoun, Jean Paul Cano, J. A. Gastaut, Isabelle Thuret, J Gäbert, J.A. Gastaut and N. Tubiana-Mathieu and has published in prestigious journals such as The Lancet, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Y Carcassonne

111 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Carcassonne France 17 399 278 189 179 177 115 1.1k
DJ Weisdorf United States 15 768 1.9× 390 1.4× 157 0.8× 257 1.4× 216 1.2× 19 1.4k
J Pris France 22 571 1.4× 424 1.5× 345 1.8× 243 1.4× 191 1.1× 79 1.3k
R Leblay France 9 229 0.6× 294 1.1× 380 2.0× 269 1.5× 161 0.9× 31 832
JW Fay United States 18 482 1.2× 384 1.4× 245 1.3× 212 1.2× 164 0.9× 38 1.4k
Stanley L. Lee United States 24 290 0.7× 180 0.6× 162 0.9× 223 1.2× 174 1.0× 36 1.7k
M. A. Boogaerts Belgium 20 823 2.1× 242 0.9× 262 1.4× 266 1.5× 135 0.8× 29 1.2k
Lyle L. Sensenbrenner United States 15 1.1k 2.6× 444 1.6× 216 1.1× 252 1.4× 297 1.7× 28 1.6k
Antonella Geromin Italy 21 641 1.6× 549 2.0× 179 0.9× 316 1.8× 157 0.9× 55 1.2k
H.M. Clink United Kingdom 15 718 1.8× 519 1.9× 147 0.8× 200 1.1× 147 0.8× 19 1.6k
P. C. Vincent Australia 15 228 0.6× 167 0.6× 139 0.7× 135 0.8× 90 0.5× 59 817

Countries citing papers authored by Y Carcassonne

Since Specialization
Citations

This map shows the geographic impact of Y Carcassonne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Carcassonne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Carcassonne more than expected).

Fields of papers citing papers by Y Carcassonne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Carcassonne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Carcassonne. The network helps show where Y Carcassonne may publish in the future.

Co-authorship network of co-authors of Y Carcassonne

This figure shows the co-authorship network connecting the top 25 collaborators of Y Carcassonne. A scholar is included among the top collaborators of Y Carcassonne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Carcassonne. Y Carcassonne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tubiana-Mathieu, N., et al.. (1994). Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment. European Journal of Cancer. 30(9). 1281–1284. 2 indexed citations
2.
Lejeune, Catherine, N. Tubiana-Mathieu, J.A. Gastaut, et al.. (1990). High‐dose cytosine arabinoside and mitoxantrone in previously‐treated acute leukemia patients. European Journal Of Haematology. 44(4). 240–243. 13 indexed citations
3.
Seitz, Jean François, Marc Giovannini, P. Fuentès, et al.. (1990). Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer. 66(2). 214–219. 62 indexed citations
4.
Resbeut, M., Didier Blaise, D Maraninchi, et al.. (1990). Results of fractionated TBI prior to bone marrow transplantation in standard risk leukaemia at Marseille. Radiotherapy and Oncology. 18. 132–134. 1 indexed citations
5.
Pellissier, J F, et al.. (1987). Neuropathies et infections par le retrovirus hiv. Revue d Electroencé phalographie et de Neurophysiologie Clinique. 17(4). 425–435. 5 indexed citations
6.
Gastaut, J. A., et al.. (1987). Neuropathie périphérique et infection par le rétrovirus HIV.. La Presse Médicale. 16(21). 1057–1057. 1 indexed citations
7.
Drancourt, Michel, N. Tubiana-Mathieu, J. A. Gastaut, et al.. (1987). [Chronic lymphoid leukemia in young subjects].. PubMed. 29(6). 379–82. 5 indexed citations
8.
Tubiana-Mathieu, N., et al.. (1987). Etoposide and cisplatinum in resistant lymphomas. Cancer Chemotherapy and Pharmacology. 20(2). 179–80. 6 indexed citations
9.
Tubiana-Mathieu, N., et al.. (1987). [Lymphocyte phenotyping in the cord blood of newborn infants].. PubMed. 35(2). 184–6. 2 indexed citations
10.
Tubiana-Mathieu, N., et al.. (1986). Quantification of oestradiol binding at the surface of human lymphocytes by flow cytofluorimetry. British Journal of Cancer. 54(3). 501–504. 14 indexed citations
11.
Aubert, C., et al.. (1983). [Chemotherapy of extensive digestive cancers with 5-fluorouracil: relation between the clinical response and plasma clearance of the drug].. PubMed. 7(4). 374–80. 15 indexed citations
12.
Gastaut, J A, et al.. (1979). [Association for ankylosing spondylarthritis multiple myeloma. A case history (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55(27-30). 1335–7. 3 indexed citations
13.
Carcassonne, Y, et al.. (1978). Acute leukemia after prolonged immunosuppressive therapy for glomerulonephritis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(7). 1110–1. 5 indexed citations
14.
Carcassonne, Y, et al.. (1978). [Oncogenic effects of cytostatic chemotherapy. Apropos of 4 cases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 129(3). 181–5. 1 indexed citations
15.
Gastaut, J L, et al.. (1978). Computerized axial tomography in the study of intracranial complications in hematology. Cancer. 41(2). 487–501. 9 indexed citations
16.
Carcassonne, Y, J. A. Gastaut, G Sébahoun, & N Gratecos. (1977). Découverte simultanée chez un même malade d'un myélome, d'une leucémie granuleuse (à polynucléaires neutrophiles et d'une maladie de Paget.. 18(1). 5 indexed citations
17.
Carcassonne, Y, J. A. Gastaut, G Sébahoun, & N Gratecos. (1977). [Simultaneous discovery of myeloma, granulocytic leukemia (with polynuclear neutrophils) and Paget's disease in a patient].. PubMed. 18(1). 240–4. 1 indexed citations
18.
Carcassonne, Y, et al.. (1977). [Recurrence of acute lymphoblastic leukemia after 15 years of complete remission].. PubMed. 128(8-9). 711–4. 1 indexed citations
19.
Ja, Gastaut, et al.. (1976). [Periarteritis nodosa with Rickettsia-positive serology].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(10). 639–40. 1 indexed citations
20.
Carcassonne, Y. (1957). [Treatment of acute purulent meningitis].. PubMed. 94(5). 357–62.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026